Financial economics

Radius Health Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Retrieved on: 
Tuesday, April 28, 2020
Financial markets, Finance, Corporate finance, Financial economics, Stock market, Inheritance, Labour law, Property law, Vesting, Option, Stock, NASDAQ

In addition, the Board granted Mr. Martin an option (the Performance-Based Option) to purchase 575,000 shares of the Companys common stock at the Exercise Price, subject to performance-based vesting conditions.

Key Points: 
  • In addition, the Board granted Mr. Martin an option (the Performance-Based Option) to purchase 575,000 shares of the Companys common stock at the Exercise Price, subject to performance-based vesting conditions.
  • The Performance-Based Option will not vest prior to the one-year anniversary of the Grant Date.
  • Both stock options were granted as an inducement material to Mr. Martin entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4).
  • Radius is a science-driven fully integrated biopharmaceutical company that is committed to developing and commercializing innovative endocrine therapeutics.

Blucora Announces Employee Inducement Equity Grant

Retrieved on: 
Tuesday, April 28, 2020
Financial markets, Corporate finance, Stock market, Finance, Financial economics, Blucora, Stock, Restricted stock, Tax

Both the restricted stock units and the shares underlying the non-qualified stock option will vest in three equal annual installments beginning on the first anniversary of the of the date of grant.

Key Points: 
  • Both the restricted stock units and the shares underlying the non-qualified stock option will vest in three equal annual installments beginning on the first anniversary of the of the date of grant.
  • Blucora, Inc. (NASDAQ: BCOR) is on the forefront of financial technology, pioneering tax-smart financial solutions that empower people to achieve their goals.
  • With integrated tax and wealth management, Blucora is uniquely positioned to provide better long-term outcomes for customers with holistic, tax-advantaged solutions.
  • For more information on Blucora, visit www.blucora.com.

Intercontinental Exchange to Hold Virtual 2020 Annual Meeting of Stockholders

Retrieved on: 
Tuesday, April 28, 2020
Professional services, Finance, Financial economics, Corporate finance, Finance, Equity securities, Money, Proxy, Annual general meeting, Stock

Intercontinental Exchange (NYSE: ICE), a leading operator of global exchanges and clearing houses and provider of data and listings services, announced today that, due to the public health impact of the coronavirus (COVID-19) pandemic and to prioritize the health and well-being of its employees, stockholders and community, ICEs 2020 Annual Meeting of Stockholders (Annual Meeting) has been changed from an in-person meeting to a virtual format only.

Key Points: 
  • Intercontinental Exchange (NYSE: ICE), a leading operator of global exchanges and clearing houses and provider of data and listings services, announced today that, due to the public health impact of the coronavirus (COVID-19) pandemic and to prioritize the health and well-being of its employees, stockholders and community, ICEs 2020 Annual Meeting of Stockholders (Annual Meeting) has been changed from an in-person meeting to a virtual format only.
  • The original date and time of the Annual Meeting, as well as the items of business to be addressed at the Annual Meeting, remain unchanged.
  • The details for the virtual meeting are:
    Stockholders of record at the close of business on March 17, 2020, will be able to participate in the virtual meeting, vote shares electronically, and submit questions during the live webcast of the meeting by using the instructions on the virtual meeting website.
  • Whether or not stockholders plan to attend the virtual meeting, all stockholders are encouraged to vote their shares in advance through www.proxyvote.com , toll-free phone number, or mail, as communicated in the previously-distributed proxy materials for the Annual Meeting.

PAR Technology Corporation Releases Conference Call and Webcast Information for Fiscal 2020 First Quarter Financial Results

Retrieved on: 
Tuesday, April 28, 2020
Software, Restaurant, Bar, Other Retail, Hardware, Data management, Technology, Food, Beverage, Retail, Financial markets, Equity securities, Stock market, Financial economics, Finance, Corporate finance, Stock, New York Stock Exchange

PAR Technology Corporation (NYSE: PAR) today announced that it will report its first quarter financial results on Thursday, May 7, 2020.

Key Points: 
  • PAR Technology Corporation (NYSE: PAR) today announced that it will report its first quarter financial results on Thursday, May 7, 2020.
  • PAR Technology President and Chief Executive Officer Savneet Singh, Chief Financial Officer Bryan Menar and VP for Business Development, Christopher Byrnes will provide a business update and address questions from call participants.
  • PAR Technology Corporation is a customer success-driven, global restaurant and retail technology company with over 100,000 restaurants in more than 110 countries using its point of sale hardware and software.
  • PAR Technology Corporations stock is traded on the New York Stock Exchange under the symbol PAR.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Phoenix Tree Holdings Limited (DNK) on Behalf of Investors

Retrieved on: 
Tuesday, April 28, 2020
Legal, Professional services, Financial economics, Finance, Stock market, Corporate finance, Financial markets, Initial public offering, Public offering, Stock, Security

Law Offices of Howard G. Smith announces an investigation on behalf of Phoenix Tree Holdings Limited ("Phoenix" or the "Company") (NYSE: DNK ) investors concerning the Company and its officers possible violations of federal securities laws.

Key Points: 
  • Law Offices of Howard G. Smith announces an investigation on behalf of Phoenix Tree Holdings Limited ("Phoenix" or the "Company") (NYSE: DNK ) investors concerning the Company and its officers possible violations of federal securities laws.
  • On or about January 17, 2020, the Company sold 9.6 million shares of stock in its initial public stock offering (IPO), at $13.50 a share, raising $130 million in new capital.
  • On this news, the Companys shares are now trading at $6.59, which is about 51% below the IPO price.
  • This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against iQIYI, Inc. (IQ)

Retrieved on: 
Tuesday, April 28, 2020
Legal, Professional services, Financial markets, Corporate finance, Financial economics, Baidu, iQiyi, Equity securities, American depositary receipt, Stock market, Initial public offering, Share price

Glancy Prongay & Murray LLP (GPM) reminds investors of the upcoming June 15, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of purchased iQIYI, Inc. ("iQIYI" or the Company") (NASDAQ: IQ ) investors who purchased securities between March 29, 2018 and April 7, 2020, inclusive (the Class Period).

Key Points: 
  • Glancy Prongay & Murray LLP (GPM) reminds investors of the upcoming June 15, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of purchased iQIYI, Inc. ("iQIYI" or the Company") (NASDAQ: IQ ) investors who purchased securities between March 29, 2018 and April 7, 2020, inclusive (the Class Period).
  • On March 29, 2018, iQIYI conducted its initial public offering (IPO), issuing 125,000,000 American Depositary Shares (ADSs) priced at $18.00 per share.
  • On this news, the Companys share price fell $0.79, or over 4%, to close at $16.51 per share on April 8, 2020, thereby injuring investors.
  • To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.

Thinking about buying stock in Aytu Bioscience, SmileDirectClub, Ocular Therapeutix, Six Flags Entertainment, or MGM Resorts?

Retrieved on: 
Tuesday, April 28, 2020
Finance, Stock market, Financial economics, Money, Corporate finance, Communication design, Design, Film production, Multimedia, Metro-Goldwyn-Mayer, Stock

InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology.

Key Points: 
  • InvestorsObserver's PriceWatch Alerts are based on our proprietary scoring methodology.
  • Each stock is evaluated based on short-term technical, long-term technical and fundamental factors.
  • Each of those scores is then combined into an overall score that determines a stock's overall suitability for investment.
  • View original content to download multimedia: http://www.prnewswire.com/news-releases/thinking-about-buying-stock-in-a...

NeuBase Therapeutics Announces Pricing of $31,500,000 Public Offering of Common Stock

Retrieved on: 
Tuesday, April 28, 2020
Financial markets, Financial economics, Finance, Corporate finance, Initial public offering, Stock market, Underwriting, Actuarial science, Gene silencing, Stock, Public offering, Greenshoe

The gross proceeds to NeuBase from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by NeuBase, are expected to be approximately $31,500,000, excluding any exercise of the underwriters option to purchase additional shares of common stock.

Key Points: 
  • The gross proceeds to NeuBase from the offering, before deducting the underwriting discounts and commissions and offering expenses payable by NeuBase, are expected to be approximately $31,500,000, excluding any exercise of the underwriters option to purchase additional shares of common stock.
  • In addition, NeuBase has granted the underwriters a 30-day option to purchase up to an additional 787,500 shares of its common stock at the public offering price, less underwriting discounts and commissions, to cover over-allotments, if any.
  • All of the shares of common stock in the offering are being sold by NeuBase.
  • NeuBase Therapeutics, Inc. is developing the next generation of gene silencing therapies with its flexible, highly specific synthetic antisense oligonucleotides.

Nano Dimension Announces Closing of $13.3 Million Public Offering

Retrieved on: 
Tuesday, April 28, 2020
Financial markets, Finance, Financial economics, Initial public offering, Corporate finance, Actuarial science, Underwriting, Stock market, Public offering, American depositary receipt

The gross proceeds to the Company from this offering were approximately $13,343,000 before deducting underwriting discounts, commissions and other offering expenses.

Key Points: 
  • The gross proceeds to the Company from this offering were approximately $13,343,000 before deducting underwriting discounts, commissions and other offering expenses.
  • Nano Dimension has granted the underwriter a 45-day option to purchase additional ADSs and pre-funded warrants to cover remaining over-allotments, if any, at the public offering price, less the underwriting discounts and commissions.
  • Nano Dimension intends to use the proceeds of the offering for building up its sales and marketing infrastructure and for working capital and general corporate purposes.
  • For example, Nano Dimension is using forward-looking statements in this press release when it discusses the possible offering of additional American Depositary Shares and/or Pre-Funded Warrants and the intended use of proceeds from the offering.

EQUITY ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Announces Filing of Securities Class Action Lawsuit Against Phoenix Tree Holdings Limited – DNK

Retrieved on: 
Tuesday, April 28, 2020
Legal, Professional services, Initial public offering, Financial markets, Corporate finance, Financial economics, Securities Class Action, Security, Prospectus, U.S. Securities and Exchange Commission, United States securities law

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Phoenix Tree Holdings Limited (NYSE: DNK) pursuant and/or traceable to prospectuses and registration statements issued in connection with the Company's January 22, 2020, initial public offering (IPO).

Key Points: 
  • Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Phoenix Tree Holdings Limited (NYSE: DNK) pursuant and/or traceable to prospectuses and registration statements issued in connection with the Company's January 22, 2020, initial public offering (IPO).
  • To join the Phoenix class action, go to http://www.rosenlegal.com/cases-register-1846.html or call Phillip Kim, Esq.
  • toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
  • 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017.